Mohit Bansal
Stock Analyst at Wells Fargo
(4.76)
# 621
Out of 5,022 analysts
812
Total ratings
60.2%
Success rate
11.1%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Reiterated: Hold | $435 | $403.04 | +7.93% | 52 | Oct 2, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $65 | $61.15 | +6.30% | 45 | Sep 29, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $750 | $735.20 | +2.01% | 69 | Sep 28, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $30 | $16.76 | +79.05% | 14 | Sep 28, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 | $96.90 | +44.48% | 14 | Sep 24, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,330 | $1,142.85 | +16.38% | 69 | Sep 21, 2026 | |
| PFE Pfizer | Reiterated: Hold | $28 | $27.80 | +0.72% | 53 | Sep 21, 2026 | |
| BIIB Biogen | Reiterated: Buy | $250 | $219.88 | +13.70% | 55 | Sep 18, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $70 | $30.42 | +130.11% | 12 | Sep 15, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $80 | $57.18 | +39.91% | 28 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 → $170 | $144.30 | +17.81% | 56 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $295 → $300 | $262.82 | +14.15% | 43 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.8097 | +764.52% | 5 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $23.63 | +132.75% | 16 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $235.67 | +27.30% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 → $95 | $109.86 | -13.53% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $80 | $56.93 | +40.52% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 | $144.74 | +14.00% | 64 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $550 | $504.73 | +8.97% | 52 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $143.18 | +39.68% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.64 | +37.36% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.78 | +243.92% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $38.02 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $64.19 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $14 | $28.35 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $1.04 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $33 | $37.36 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $1.16 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $75 | $6.73 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $5 | $0.0001 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $65 | $31.80 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $8.5 | $2.56 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.037 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $15.34 | n/a | 1 | Jun 11, 2019 |
Amgen
Oct 2, 2026
Reiterated: Hold
Price Target: $435
Current: $403.04
Upside: +7.93%
Bristol-Myers Squibb Company
Sep 29, 2026
Reiterated: Hold
Price Target: $65
Current: $61.15
Upside: +6.30%
Regeneron Pharmaceuticals
Sep 28, 2026
Reiterated: Hold
Price Target: $750
Current: $735.20
Upside: +2.01%
Summit Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $30
Current: $16.76
Upside: +79.05%
BioNTech SE
Sep 24, 2026
Reiterated: Buy
Price Target: $140
Current: $96.90
Upside: +44.48%
Eli Lilly and Company
Sep 21, 2026
Reiterated: Buy
Price Target: $1,330
Current: $1,142.85
Upside: +16.38%
Pfizer
Sep 21, 2026
Reiterated: Hold
Price Target: $28
Current: $27.80
Upside: +0.72%
Biogen
Sep 18, 2026
Reiterated: Buy
Price Target: $250
Current: $219.88
Upside: +13.70%
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $70
Current: $30.42
Upside: +130.11%
BioMarin Pharmaceutical
Sep 11, 2026
Reiterated: Buy
Price Target: $80
Current: $57.18
Upside: +39.91%
Sep 4, 2026
Rated: Buy
Price Target: $150 → $170
Current: $144.30
Upside: +17.81%
Aug 17, 2026
Rated: Buy
Price Target: $295 → $300
Current: $262.82
Upside: +14.15%
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.8097
Upside: +764.52%
Aug 12, 2026
Reiterated: Buy
Price Target: $55
Current: $23.63
Upside: +132.75%
Aug 10, 2026
Reiterated: Buy
Price Target: $300
Current: $235.67
Upside: +27.30%
Aug 7, 2026
Rated: Hold
Price Target: $75 → $95
Current: $109.86
Upside: -13.53%
Aug 6, 2026
Reiterated: Buy
Price Target: $65 → $80
Current: $56.93
Upside: +40.52%
Aug 5, 2026
Rated: Buy
Price Target: $165
Current: $144.74
Upside: +14.00%
Aug 4, 2026
Rated: Buy
Price Target: $550
Current: $504.73
Upside: +8.97%
Jul 31, 2026
Rated: Buy
Price Target: $200
Current: $143.18
Upside: +39.68%
May 5, 2026
Reiterated: Hold
Price Target: $5
Current: $3.64
Upside: +37.36%
Apr 1, 2026
Reiterated: Buy
Price Target: $13
Current: $3.78
Upside: +243.92%
Aug 12, 2025
Reiterated: Buy
Price Target: $47
Current: $38.02
Upside: n/a
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $64.19
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $30 → $14
Current: $28.35
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $1.04
Upside: n/a
Mar 24, 2021
Reiterated: Buy
Price Target: $20 → $33
Current: $37.36
Upside: n/a
Feb 25, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $1.16
Upside: n/a
Jan 20, 2021
Reiterated: Buy
Price Target: $36 → $75
Current: $6.73
Upside: n/a
Jan 5, 2021
Reiterated: Buy
Price Target: $10 → $5
Current: $0.0001
Upside: n/a
Dec 23, 2020
Reiterated: Buy
Price Target: $75 → $65
Current: $31.80
Upside: n/a
Sep 15, 2020
Reiterated: Hold
Price Target: $11 → $8.5
Current: $2.56
Upside: n/a
Apr 27, 2020
Reiterated: Buy
Price Target: $8 → $5
Current: $0.037
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $15.34
Upside: n/a